CClinicalTrials.gg
CompletedNCT05376072Updated May 17, 2022

Electromyographic Biofeedback Muscle Recovery Meniscectomy

An interventional study of Electromyographic Biofeedback in Feedback, Psychological, sponsored by Western Norway University of Applied Sciences. Completed at 1 site in Spain. Open to male participants aged 24 Years to 35 Years. Per ClinicalTrials.gov, last updated 2022-05-17.

Sponsored by Western Norway University of Applied Sciences · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 4 years 4 months after the study started (first participant enrolled Jan 2018, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
24 Years to 35 Years
Sex
Male
01

Study summary

Electromyographic biofeedback (EMG-BF) is a therapeutic technique that has been used success-fully in rehabilitation of injuries. Although it has been applied in athletes, its use in this field is not very widespread. The objective of this study is to analyze its effectiveness in the recovery of electromyographic activity of the quadriceps after meniscectomy, evaluated through isometric contraction of the vastus lateralis. The sample comprised ten professional footballers in the Spanish League (2nd Division A) who had previously suffered a meniscus injury in their knee and had undergone a meniscectomy. The intervention consisted of EMG-BF treatment lasting between 6 and 10 sessions. The electromyographic signal was recorded using a Thought Tech-nology ProComp Infiniti 8-channel biofeedback unit with a sampling rate of 2048 sam-ples/seconds. For each session a within-subject ABA design of 6 or 10 trials per session was used, with three pre- and three post-measures, which determined the gain for each session.

02

Conditions studied

  • Feedback, Psychological
03

In context

Lead sponsor

Western Norway University of Applied Sciences is the lead sponsor of 15 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Partial meniscus tear
  • Meniscectomy

Exclusion criteria

Exclusion Criteria:

  • Having an injury other than a partial meniscus tear
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Experimental data

    Other: Electromyographic Biofeedback

Interventions

  • OtherElectromyographic Biofeedback

    The players performed 10 work sessions with EMG-BF. Each session was divided into three phases: (a) three trials without receiving feedback, (b) between six and ten trials with feedback of electromyographic activity, (c) three trials without feedback. In each trial, isometric contractions of the vastus lateralis were performed. During maximum effort isometric contraction, the software associated with the ProComp Infiniti biofeedback unit collects the amplitude, the mean and maximum electromyographic signal, and also the contraction and tightening times. The contrac-tion time comprises the interval between the start of the contraction and achievement of the desired muscle tension. The tightening time is the period in which the tension voluntarily reached is maintained. For this study, the maximum and mean elec-tromyographic activity values were considered, calculated during the muscle tension time and maintained during each trial.

06

What researchers measure

Primary outcomes

  1. Changes in muscle tension level

    Using electrommiographic biofeedback device, the increase in muscle tension after isometric contraction was observed. Each player performed 10 work sessions (2 sessions per week) with EMG-BF. Each session was divided into three phases: (a) three trials without receiving feedback, (b) between six and ten trials with feedback of electromyographic activity, (c) three trials without feedback. In each trial, isometric contractions of the vastus lateralis were performed. For all sessions, each isometric contraction lasted six seconds and the participants rested for two minutes between trials to recover their contraction capacity. The sampling rate was 2048 samples per second.

    Time frame: Each participant performed a total of 10 session during 5 weeks

07

Study locations

1 site
  • Antonio Hernández Mendo
    Málaga, 29010, Spain
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05376072
Lead sponsor
Western Norway University of Applied Sciences
Collaborators
University of Malaga
Responsible party
Coral Falco (Principal Investigator, Western Norway University of Applied Sciences) — Principal investigator
First posted
May 17, 2022
Start date
Jan 1, 2018
Primary completion
May 1, 2018
Completion
Jun 1, 2018
Last update
May 17, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion